System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
A Beta-2-Glycoprotein I (B2-GPI) Antibody Test System is an in vitro diagnostic device that detects and measures antibodies against beta-2-glycoprotein I in serum, an important marker for antiphospholipid syndrome, a condition associated with thrombosis and recurrent pregnancy loss. It is FDA Class 2, requiring 510(k) clearance, with product code MSV under 21 CFR 866.5660 in the Immunology specialty. The device is not an implant and is not life-sustaining.
Research product code MSV in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- MSV
- Device Class
- FDA class 2
- Regulation Number
- 866.5660
- Medical Specialty
- Immunology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 46 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K243979 | Aptiva APS IgA Reagent | Feb 06, 2026 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K181329 | EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay | Jun 25, 2018 | Substantially Equivalent | Phadia AB |
| K162788 | ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA | Jun 19, 2017 | Substantially Equivalent | Immco Diagnostics, Inc. |
| K152875 | QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls | Dec 21, 2015 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K141274 | QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS. | Feb 13, 2015 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K112414 | ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY | Jun 22, 2012 | Substantially Equivalent | Phadia US, Inc. |
| K091556 | HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLS | May 21, 2010 | Substantially Equivalent | Instrumentation Laboratory CO |
| K092757 | THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR | Oct 09, 2009 | Substantially Equivalent | Thera-Test Laboratories, Inc. |
| K072032 | IGG ANTI-ATHEROX TEST KIT | Apr 04, 2008 | Substantially Equivalent | Corgenix, Inc. |
| K062217 | AESKULSKA BETA2-GLYCO-A | Dec 13, 2006 | Substantially Equivalent | Aesku, Inc. |
| K040452 | VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096 | May 11, 2004 | Substantially Equivalent | Pharmacia Deutschland GmbH |
| K040451 | VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896 | May 11, 2004 | Substantially Equivalent | Pharmacia Deutschland GmbH |
| K040450 | VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996 | May 11, 2004 | Substantially Equivalent | Pharmacia Deutschland GmbH |
| K040449 | VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796 | May 11, 2004 | Substantially Equivalent | Pharmacia Deutschland GmbH |
| K030702 | IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGM ELISA | Sep 09, 2003 | Substantially Equivalent | Immco Diagnostics, Inc. |
| K030701 | IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISA | Sep 09, 2003 | Substantially Equivalent | Immco Diagnostics, Inc. |
| K031208 | REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001 | Jul 07, 2003 | Substantially Equivalent | Corgenix, Inc. |
| K031177 | DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M | Jun 19, 2003 | Substantially Equivalent | Axis-Shield Diagnostics, Ltd. |
| K030397 | AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGA ELISA | Mar 21, 2003 | Substantially Equivalent | Hycor Biomedical , Ltd. |
| K022945 | AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGG ELISA | Dec 18, 2002 | Substantially Equivalent | Hycor Biomedical, Inc. |
| K022944 | AUTOSTAT II ANTI-B-2 GLYCOPROTEIN-I IGM ELISA | Dec 18, 2002 | Substantially Equivalent | Hycor Biomedical, Inc. |
| K021611 | QAB2A IGG ELISA KIT HRP | Jul 12, 2002 | Substantially Equivalent | Cheshire Diagnostics , Ltd. |
| K021610 | QAB2A IGM ELISA KIT HRP | Jul 12, 2002 | Substantially Equivalent | Cheshire Diagnostics , Ltd. |
| K020695 | QAB2A IGG ELISA KIT | Apr 19, 2002 | Substantially Equivalent | Cheshire Diagnostics , Ltd. |
| K013956 | DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I SCREEN | Jan 08, 2002 | Substantially Equivalent | Diamedix Corp. |
| K013628 | DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I IGG/IGM TEST SYSTEM | Dec 21, 2001 | Substantially Equivalent | Diamedix Corp. |
| K013080 | REAADS ANTI-BETA 2 GLYCOPROTEIN I IGG TEST KIT | Sep 28, 2001 | Substantially Equivalent | Corgenix, Inc. |
| K013079 | REAADS ANTI-BETA 2 GLYCOPROTEIN I IGA TEST KIT | Sep 28, 2001 | Substantially Equivalent | Corgenix, Inc. |
| K013077 | REAADS ANTI-BETA 2 GLYCOPROTEIN I IGM TEST KIT | Sep 28, 2001 | Substantially Equivalent | Corgenix, Inc. |
| K991804 | BINDAZYME ANTI-B2 SCREEN EIA TEST KIT. | May 05, 2000 | Substantially Equivalent | The Binding Site, Ltd. |
| K991803 | BINDAZYME ANTI B2 GP1 IGM EIA TEST KIT. | May 05, 2000 | Substantially Equivalent | The Binding Site, Ltd. |
| K991802 | BINDAZYME ANTI-B2 GP1 IGA EIA TEST KIT | May 05, 2000 | Substantially Equivalent | The Binding Site, Ltd. |
| K991801 | BINDAZYME ANTI-B2 GP1 IGG EIA TEST KIT | May 05, 2000 | Substantially Equivalent | The Binding Site, Ltd. |
| K992243 | VIRGO BETA 2 GLYCOPROTEIN IGM ANTIBODY KIT | Aug 30, 1999 | Substantially Equivalent | Hemagen Diagnostics, Inc. |
| K992241 | VIRGO B2 GLYCOPROTEIN I IGA ANTIBODY KIT | Aug 30, 1999 | Substantially Equivalent | Hemagen Diagnostics, Inc. |
| K992224 | VIRGO BETA 2 GLYCOPROTEIN IGG ANTIBODY KIT | Aug 30, 1999 | Substantially Equivalent | Hemagen Diagnostics, Inc. |
| K982434 | REAADS IGA ANTI-B2GP 1 TEST KIT | Dec 22, 1998 | Substantially Equivalent | Corgenix, Inc. |
| K982433 | REAADS IGM ANTI-B2GP1 TEST KIT | Dec 07, 1998 | Substantially Equivalent | Corgenix, Inc. |
| K982391 | REAADS IGG ANTI-B2GPI TEST KIT | Dec 07, 1998 | Substantially Equivalent | Corgenix, Inc. |
| K982879 | SHIELD DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGG (ELISA) ASSAY | Oct 15, 1998 | Substantially Equivalent | Shield Diagnostics, Ltd. |
| K980230 | QUANTA LITE B2 GPI SCREEN | Mar 24, 1998 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K973882 | EL-B2GP1SCR | Dec 05, 1997 | Substantially Equivalent | Theratest Laboratories, Inc. |
| K972790 | THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR | Dec 05, 1997 | Substantially Equivalent | Theratest Laboratories, Inc. |
| K973014 | QUANTA LITE B2GPI IGM | Oct 20, 1997 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K973006 | QUANTA LITE B2 GPI IGA | Oct 20, 1997 | Substantially Equivalent | Inova Diagnostics, Inc. |
| K970551 | QUANTA LITE B2GPI IGG | Jun 24, 1997 | Substantially Equivalent | Inova Diagnostics, Inc. |
FEI Numbers
This FDA classification entry is associated with 19 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 19 registration numbers. Click on an entry to view related FDA registrations.